Folic acid

Folic acid has been studied in 221 papers since 1982: 26 trials and 104 observational studies in people, 27 in animals, 60 reviews; 60 in the past year. It is an approved medicine. The newest story, Nov 10, 2026: “Exercise plus folic acid may improve metabolism in men with obesity”.

InterventionApproved 1947

221 papers study it129 more mention it172 findingsUpdated

PubChemChEBIMeSH

Research on it is growing 39% slower than aging research as a whole: 10 papers in the latest year counted

8 new papers in 30 daysSee all 350 papers on folic acid

At a glance

Folic acid reduces cellular senescence in mice, a change reproduced by independent labs; a human trial reports reduced biological age. Human cognitive results include improvement and no clear effect, while cohorts link folic acid with both lower cognitive-impairment risk and higher dementia risk. Independent labs reproduce homocysteine reductions in humans; an author has a Hamad Medical Corporation affiliation.

172 findings in 95 papers from 1997 to 2026, 8 of them since May 2026

Independent labs found the same change in mice and people. 67 independent labs in 17 countries; 173 trials, 9 about aging, 75 with no results posted.

“The treatment effect of folic acid was significantly larger in participants in the low compared to high ω-3 fatty acid tertile for global cognition”
Positive effects of folic acid supplementation on cognitive aging are dependent on ω-3 fatty acid status: a post hoc analysis of the FACIT trialThe American journal of clinical nutrition2021doi:10.1093/ajcn/nqaa373

15 of its findings point the other way.

Mice and humans: replicated by independent labs. Cells and worms or flies: a single group.
  • 67 independent labs in 17 countries
  • 15 findings against
  • 173 trials, 9 about aging, 75 with no results posted
  • Funders: National Natural Science Foundation of China and others
  • 2 of 165 findings with company ties
  • 2 of 173 trials sponsored by its developers
  • Human trial26
  • Humans104
  • Animals25
  • Model organisms2
  • In silico4

12 studies gave folic acid to people and measured what changed.

What changedDesignPeopleSource

up: Increases skeletal muscle

down: Decreases homocysteine

up: Increases HDL-C+0.21 ± 0.24 mmol/L vs -0.01 ± 0.12 mmol/L

Randomized trial9 weeks40 peoplemenoverall mean age of the participants was 22.16 yearsHealthy young adult men with no prior structured resistance-training or aerobic-training experienceJournal of the International Society of Sports Nutrition, Aug 21, 2026

no change: Has no effect on endothelial sensitivity to exercise-induced shear rateP = 0.887

Randomized trialacute17 peopleWomen66 ± 8 yrOlder adults; Postmenopausal women; handgrip exerciseAmerican journal of physiology. Heart and circulatory physiology, Jan 6, 2026

no change: Has no effect on heart rate

Trial120 min12 peoplesix female74 ± 6 years oldOlder adults representative of the population in this age group with respect to body size and aerobic fitnessExperimental physiology, Jul 7, 2025

down: Decreases biological age-2.6 years

down: Decreases cell-free DNA

up: Increases DNA methylation+1.9%

Trialan average of four months43 peoplePatients diagnosed with hyperhomocysteinemiaNutrients, Jun 27, 2025

down: Decreases homocysteine

Randomized trial6 months160 peopleover the age of 60MCI patientsJournal of Alzheimer's disease reports, Sep 27, 2024

What did lifespan studies of folic acid find?

DrugAge

DrugAge records 4 results from 1 paper: 4 in C. elegans. Average lifespan is the mean or the median, as each paper reports it.

What did studies of folic acid find?

88

Studies of folic acid measured 88 outcomes; the most studied are cognitive function (9 studies), homocysteine (8) and apoptosis (5).

Cognitive function

upin humans5no changein humans2upin mice2downin humans1

9 studies
  1. Folic acid is linked with better cognitive function in humans (β = 0.107, 95% CI: -0.073, 0.287).

    “FA was positively associated with MoCA-B scores (β = 0.107, 95% CI: -0.073, 0.287)”

    Humansn = 3,880

    Ambient particulate matters are associated with attenuation or reversal of positive association between Folate and cognitive function in Chinese older adults

    BMC public health

  2. Folic acid is linked with better cognitive function in humans (β = 9.08, p = 0.04).

    “improved scores with increased folate (β = 9.08, p = 0.04)”

    Humansmalesn = 321

    Associations Between B Vitamin Interactions with Polyunsaturated Fatty Acids and Cognitive Function Among Cognitively Healthy Older People as Modified by Amyloid Status and Sex

    Nutrients

  3. Folic acid showed no clear effect on cognitive function in areas where FA food fortification policies were mandatory (SMD 0.03 (95% CI -0.06, 0.13)).

    “FA intervention did not have significant outcomes in areas where FA food fortification policies were mandatory (Z = 0.75; p = 0.45; SMD, 0.03; 95% CI, -0.06, 0.13).”

    Reviewin areas where FA food fortification policies were mandatory

    A Comparative Study Evaluating the Effectiveness of Folate-Based B Vitamin Intervention on Cognitive Function of Older Adults under Mandatory Folic Acid Fortification Policy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

    Nutrients

  4. Folic acid improves cognitive function in humans (mild cognitive impairment) (SMD = 8.36, 95 % CI = 0.79 - 1.08).

    “the majority of studies showed significant benefit from folic acid supplementation, including the FSIQ (823 individuals, standardized mean difference [SMD] = 8.36, 95 % confidence interval [CI] = 0.79 - 1.08)”

    Reviewmild cognitive impairmentn = 823

    Effects of folic acid supplementation on cognitive function and inflammation in elderly patients with mild cognitive impairment: A systematic review and meta-analysis of randomized controlled trials

    Archives of gerontology and geriatrics

  5. Folic acid impairs cognitive function in people with low B12.

    “Cognitive function test scores are lower and blood homocysteine and methylmalonic acid concentrations are higher in people with low B12 and elevated folate than in those with low B12 and nonelevated folate.”

    Reviewin people with low B12

    Excess Folic Acid and Vitamin B12 Deficiency: Clinical Implications?

    Food and nutrition bulletin

  6. Folic acid improves cognitive function in patients with MCI (SMD 1.21, 95% CI 0.87-1.55).

    “Single vitamin B (folic acid [FA]: SMD = 1.21, 95% CI = [0.87, 1.55]) supplementation may be more effective than multiple nutrients”

    Reviewin patients with MCI

    Effects of vitamins and polyunsaturated fatty acids on cognitive function in older adults with mild cognitive impairment: a meta-analysis of randomized controlled trials

    European journal of nutrition

  7. Folic acid showed no clear effect on cognitive function in patients with Alzheimer's disease and dementia.

    “the improvement in cognitive function is not significant”

    Reviewin patients with Alzheimer's disease and dementia

    Effects of folic acid, alone or in combination with other nutrients on Hcy level and cognitive function in older people: a systematic review

    Research SquarePreprint

  8. Folic acid improves cognitive function in patients with mild cognitive impairment.

    “folic acid alone or in combination with other nutrients can effectively improve cognitive function in patients with mild cognitive impairment”

    Reviewin patients with mild cognitive impairment

    Effects of folic acid, alone or in combination with other nutrients on Hcy level and cognitive function in older people: a systematic review

    Research SquarePreprint

  9. Folic acid improves cognitive function in SAMP8 mice.

    “folic acid supplementation alleviated age-related cognitive decline”

    Animalsin SAMP8 micedietbrainmales

    Folic acid alleviates age-related cognitive decline and inhibits apoptosis of neurocytes in senescence-accelerated mouse prone 8: deoxythymidine triphosphate biosynthesis as a potential mechanism

    The Journal of nutritional biochemistry

  10. Folic acid improves cognitive function in mice (aged SAMP8 mice).

    “The results demonstrated that FA supplementation delayed age-related cognitive decline and neurodegeneration in SAMP8 mice.”

    Animalsaged SAMP8 mice

    Folic acid delays age-related cognitive decline in senescence-accelerated mouse prone 8: alleviating telomere attrition as a potential mechanism

    Aging

Homocysteine

downin humans8

8 studies
  1. Folic acid decreases homocysteine in humans with resistance training.

    “In contrast, the change in Hcy differed significantly between groups, with the RF condition showing a greater reduction than the control and RT conditions (both P < 0.05; ).”

    Human trialwith resistance training9 weeksmalesn = 40

    Effects of folic acid combined with resistance training on body composition and blood biomarkers in adult males

    Journal of the International Society of Sports Nutrition

  2. Folic acid decreases homocysteine in humans (from 16.3 ± 4.8 to 15.4 ± 5.5 μmol/L).

    “In parallel, the HCY level was moderately decreased (from 16.3 ± 4.8 to 15.4 ± 5.5 μmol/L).”

    Human trialan average of four monthsn = 43

    Examination of Genetic and Epigenetic Characteristics of Patients with Hyperhomocysteinemia Following High-Dose Folic Acid Consumption

    Nutrients

  3. Folic acid decreases homocysteine in humans (hyperhomocysteinemia in responders) (from 15.7 ± 5.5 to 11 ± 2.9 μmol/L).

    “FA responders showed decreased HCY from 15.7 ± 5.5 to 11 ± 2.9 μmol/L, while in FA non-responders, an opposite trend was detected.”

    Human trialhyperhomocysteinemia in respondersplasmahigh-dose

    Examination of Genetic and Epigenetic Characteristics of Patients with Hyperhomocysteinemia Following High-Dose Folic Acid Consumption

    Nutrients

  4. Folic acid decreases homocysteine in humans.

    “After intervention, serum Hcy levels in the FA+DHA group and FA group were significantly lower than that in control group (p < 0.05).”

    Human trial6 months

    Cognitive Function After Stopping Folic Acid and DHA Intervention: An Extended Follow-Up Results from the Randomized, Double Blind, Placebo-Controlled Trial in Older Adults with Mild Cognitive Impairment

    Journal of Alzheimer's disease reports

  5. Folic acid decreases homocysteine in humans (mild cognitive impairment; compared with conventional treatment at 12 months) (ηp2 = 0.644; P = 0.009).

    “Significant improvements in folate (ηp2 = 0.703, P = 0.011), homocysteine (ηp2 = 0.644, P = 0.009)”

    Human trialmild cognitive impairment; compared with conventional treatment at 12 months400 μg/day12 months

    Folic acid supplementation improves cognitive function by reducing the levels of peripheral inflammatory cytokines in elderly Chinese subjects with MCI

    Scientific reports

  6. Folic acid decreases homocysteine in humans (chronic stable renal transplant recipients with B6 and B12 co-supplementation).

    “mean percent reductions (+/-SEM) in fasting tHcy were as follows: group 1, 32.3+/-2.4%; group 2, 23.4+/-2.3%; and group 3, 19.1+/-2.3%.”

    Human trialchronic stable renal transplant recipients with B6 and B12 co-supplementation2.4 mg/d12 weeksn = 60

    Enhanced reduction of fasting total homocysteine levels with supraphysiological versus standard multivitamin dose folic acid supplementation in renal transplant recipients

    Arteriosclerosis, thrombosis, and vascular biology

  7. Folic acid decreases homocysteine in chronic kidney disease (MD, -8.09 μmol/L; 95% CI, -11.54 to -4.63).

    “Folate-based supplementation significantly lowered plasma homocysteine (14 RCTs; MD, -8.09 μmol/L; 95% CI, -11.54 to -4.63; I2 = 98%)”

    Reviewin chronic kidney disease

    Effect of Folate-Based Supplementation in Kidney Disease: A Systematic Review and Meta-analysis of Kidney, Cardiovascular, and Mortality Outcomes

    Nutrition reviews

  8. Folic acid decreases homocysteine in humans (mild cognitive impairment).

    “folic acid supplementation had a significant effect on the reduction of most inflammatory cytokines, blood biomarkers of Alzheimer's disease, and Hcy.”

    Reviewmild cognitive impairment

    Effects of folic acid supplementation on cognitive function and inflammation in elderly patients with mild cognitive impairment: A systematic review and meta-analysis of randomized controlled trials

    Archives of gerontology and geriatrics

  9. Folic acid decreases homocysteine in patients with Alzheimer's disease and dementia.

    “folic acid alone or in combination with other nutrients can reduce the level of homocysteine”

    Reviewin patients with Alzheimer's disease and dementia

    Effects of folic acid, alone or in combination with other nutrients on Hcy level and cognitive function in older people: a systematic review

    Research SquarePreprint

More on Homocysteine

Apoptosis

downin mice3upin mice1downin rats1

5 studies
  1. Folic acid induces apoptosis in SOD1-G93A mice.

    “Concurrently, high-dose FA induced increased apoptosis in SOD1-G93A mice, as demonstrated by TUNEL staining.”

    Animalsin SOD1-G93A micehigh-dose

    The role of overdose folic acid in promoting neuroinflammation, oxidative stress, and apoptosis in SOD1-G93A mice

    Free radical research

  2. Folic acid inhibits apoptosis in rats.

    “FA supplementation alleviated telomere length shortening and inhibited neurocyte apoptosis during the 22-month intervention.”

    Animalsbrain22 monthsmales

    Folic acid alleviated oxidative stress-induced telomere attrition and inhibited apoptosis of neurocytes in old rats

    European journal of nutrition

  3. Folic acid prevents apoptosis in triple-transgenic late-stage Alzheimer's disease mice.

    “folic acid and folinic acid promote cardiac cell survival and prevent apoptosis to inhibit heart damage in aging mice with triple-transgenic late-stage Alzheimer's disease”

    Animalsin triple-transgenic late-stage Alzheimer's disease miceheart12 mg/kg once daily3 months

    Folic Acid and Folinic Acid Protect Hearts of Aging Triple-transgenic Alzheimer's Disease mice via IGF1R/PI3K/AKT and SIRT1/AMPK Pathways

    Neurotoxicity research

  4. Folic acid inhibits apoptosis in mice.

    “FA supplementation inhibited age-associated NSC apoptosis”

    Animalscerebral cortex6 monthsmales

    Folic acid protects against age-associated apoptosis and telomere attrition of neural stem cells in senescence-accelerated mouse prone 8

    Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme

  5. Folic acid inhibits apoptosis in SAMP8 mice.

    “inhibited apoptosis of neurocytes by increasing TS expression in SAMP8 mice”

    Animalsin SAMP8 micedietbrainmales

    Folic acid alleviates age-related cognitive decline and inhibits apoptosis of neurocytes in senescence-accelerated mouse prone 8: deoxythymidine triphosphate biosynthesis as a potential mechanism

    The Journal of nutritional biochemistry

More on Apoptosis

Inflammation

upin mice2downin humans1

3 studies
  1. Folic acid increases inflammation in SOD1-G93A mice.

    “we observed that an overdose of FA significantly elevated inflammation levels in the cerebellum”

    Animalsin SOD1-G93A micecerebellumoverdose

    The role of overdose folic acid in promoting neuroinflammation, oxidative stress, and apoptosis in SOD1-G93A mice

    Free radical research

  2. Folic acid decreases inflammation in humans (mild cognitive impairment).

    “folic acid supplementation had a significant effect on the reduction of most inflammatory cytokines, blood biomarkers of Alzheimer's disease, and Hcy.”

    Reviewmild cognitive impairment

    Effects of folic acid supplementation on cognitive function and inflammation in elderly patients with mild cognitive impairment: A systematic review and meta-analysis of randomized controlled trials

    Archives of gerontology and geriatrics

  3. Folic acid increases inflammation in mice (comparison of old (1-year-old) with young (3-month-old) mice given folic acid).

    “Tubular damage score, KIM-1 expression, the recruitment of infiltrating immune cells (mainly neutrophils and macrophages) and proinflammatory gene expression were higher in AKI kidneys of old than of young mice.”

    Animalscomparison of old (1-year-old) with young (3-month-old) mice given folic acidkidney48 h

    Acute Kidney Injury is Aggravated in Aged Mice by the Exacerbation of Proinflammatory Processes

    Frontiers in pharmacology

More on Inflammation

Cellular senescence

downin mice2upin mice1

3 studies
  1. Folic acid decreases cellular senescence in mice (irradiated lungs).

    “folic acid mitigated radiation-induced DNA damage and cellular senescence in lung tissues and lung epithelial cell lines.”

    Animalsirradiated lungs

    Folic Acid Protects Against Radiation-Induced Lung Injury by Suppressing Senescence of Lung Epithelial Cells

    Molecular carcinogenesis

  2. Folic acid increases cellular senescence in mice (p21cip1 and γH2AX in old vs young folic acid-induced AKI mice).

    “p21cip1 mRNA expression and nuclear staining for p21cip1 and γH2AX were higher in old than in young FA-AKI mice”

    Animalsp21cip1 and γH2AX in old vs young folic acid-induced AKI micekidney48 h

    Acute Kidney Injury is Aggravated in Aged Mice by the Exacerbation of Proinflammatory Processes

    Frontiers in pharmacology

  3. Folic acid decreases cellular senescence in mice.

    “folic acid attenuated cardiac senescence by down-regulating p53/p21/p16 levels”

    Animalsdietheart6 monthsmales

    Folic acid attenuates remodeling and dysfunction in the aging heart through the ER stress pathway

    Life sciences

More on Cellular senescence

Oxidative stress and ROS signaling

downin mice2downin rats1

3 studies
  1. Folic acid decreases oxidative stress and ROS signaling in rats.

    “FA supplementation increased folate concentrations and antioxidant activities while decreasing Hcy, ROS, and 8-OHdG levels in rat brain tissue”

    Animalsbrain22 monthsmales

    Folic acid alleviated oxidative stress-induced telomere attrition and inhibited apoptosis of neurocytes in old rats

    European journal of nutrition

  2. Folic acid decreases oxidative stress and ROS signaling in mice.

    “decreased levels of oxidative damage”

    Animalscerebral cortex6 monthsmales

    Folic acid protects against age-associated apoptosis and telomere attrition of neural stem cells in senescence-accelerated mouse prone 8

    Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme

  3. Folic acid decreases oxidative stress and ROS signaling in mice.

    “LV remodeling, fibrosis, apoptosis and oxidative stress were also reduced in mice that consumed folic acid.”

    Animalsdietheart6 monthsmales

    Folic acid attenuates remodeling and dysfunction in the aging heart through the ER stress pathway

    Life sciences

More on Oxidative stress and ROS signaling

Lifespan

downin mice1upin mice1downin worms1

2 studies
  1. Folic acid shortens lifespan in SOD1-G93A mice.

    “medium and high-dose FA significantly shortened the lifespan of the SOD1-G93A mice.”

    Animalsin SOD1-G93A micemedium and high-dose

    The role of overdose folic acid in promoting neuroinflammation, oxidative stress, and apoptosis in SOD1-G93A mice

    Free radical research

  2. Folic acid extends lifespan in SOD1-G93A mice.

    “Our results indicated that a little FA prolonged the lifespan of the SOD1-G93A mice”

    Animalsin SOD1-G93A micelow-dose

    The role of overdose folic acid in promoting neuroinflammation, oxidative stress, and apoptosis in SOD1-G93A mice

    Free radical research

  3. Folic acid decreases lifespan in worms (fed PABA-synthesis-defective E. coli, reversing its lifespan extension).

    “This pathway restores folate synthesis in a bacterial mutant defective in PABA synthesis, reversing the ability of this mutant to increase C. elegans lifespan.”

    Model organismsfed PABA-synthesis-defective E. coli, reversing its lifespan extension

    A bacterial route for folic acid supplementation

    BMC biology

Cardiovascular disease

no changein humans2RR 0.88

2 studies
  1. Folic acid was not clearly linked with cardiovascular disease in humans among women with a history of a CHD-affected pregnancy.

    “Periconceptional folic acid supplementation, alone, does not lower CVD risk among women with CHD-affected pregnancy.”

    Humansamong women with a history of a CHD-affected pregnancysupplement

    Is Periconceptional Folic Acid Supplementation Associated with Cardiovascular Disease Risk Later in Life among Women who Delivered a Child with Congenital Heart Disease?

    AHA Scientific Sessions 2025 abstract

  2. Folic acid showed no clear effect on cardiovascular disease in chronic kidney disease (RR, 0.88; 95% CI, 0.68-1.13).

    “However, no statistically significant reductions were observed in cardiovascular events (6 RCTs; RR, 0.88; 95% CI, 0.68-1.13; I2 = 13%)”

    Reviewin chronic kidney disease

    Effect of Folate-Based Supplementation in Kidney Disease: A Systematic Review and Meta-analysis of Kidney, Cardiovascular, and Mortality Outcomes

    Nutrition reviews

More on Cardiovascular disease

DNA methylation

upin humans1no changein humans1+1.9%

2 studies
  1. Folic acid increases DNA methylation in humans (+1.9%).

    “Elevated methylation levels of LINE-1 regions were observed in cfDNA and PBMC-origin DNA samples following the consumption of high-dose folic acid (p < 0.05), with mean relative changes in methylation of 1.9% for both sample types.”

    Human trialan average of four monthsn = 43

    Examination of Genetic and Epigenetic Characteristics of Patients with Hyperhomocysteinemia Following High-Dose Folic Acid Consumption

    Nutrients

  2. Folic acid showed no clear effect on DNA methylation in humans.

    “No notable changes in the methylome resulting from the folic acid supplementation emerged.”

    Human trialperipheral blood leukocytes8 weeksmalesn = 16

    Impact of folic acid supplementation on the epigenetic profile in healthy unfortified individuals - a randomized intervention trial

    Epigenetics

More on DNA methylation

Frailty

no changein humans1no changein silico1

2 studies
  1. Folic acid was not clearly linked with frailty in humans.

    “B12 and FO levels showed no relationship with frailty incidence.”

    Humanssix-yearn = 875

    Homocysteine, Folic Acid, Cyanocobalamin, and Frailty in Older People: Findings From the "Invece. Ab" Study

    Frontiers in physiology

  2. Folic acid showed no clear effect on frailty in silico (β 0.029, 95% CI -0.013 to 0.072).

    “0.029 (95% CI: -0.013, 0.072; folic acid)”

    In silico

    A Mendelian Randomisation Study to Examine the Causal Associations of Circulating Micronutrient Levels with Frailty Risk

    Research SquarePreprint

Full-scale intelligence quotient

upin humans2

2 studies
  1. Folic acid improves full-scale intelligence quotient in humans (mild cognitive impairment, compared with placebo).

    “Daily oral FA, DHA and their combined use for 6 months significantly improved the full-scale intelligence quotient (FSIQ)”

    Human trialmild cognitive impairment, compared with placebo800 μg/d6 monthsn = 240

    Effect of folic acid combined with docosahexaenoic acid intervention on mild cognitive impairment in elderly: a randomized double-blind, placebo-controlled trial

    European journal of nutrition

  2. Folic acid improves full-scale intelligence quotient in humans (mild cognitive impairment; compared with conventional treatment at 12 months) (d = 0.153; P = 0.028).

    “Folic acid supplementation improved the Full Scale Intelligence Quotient (P = 0.028; effect size d = 0.153)”

    Human trialmild cognitive impairment; compared with conventional treatment at 12 months400 μg/day12 months

    Folic acid supplementation improves cognitive function by reducing the levels of peripheral inflammatory cytokines in elderly Chinese subjects with MCI

    Scientific reports

Hyperhomocysteinemia

downin humans2

2 studies
  1. Folic acid decreases hyperhomocysteinemia in humans (chronic stable renal transplant recipients with baseline tHcy >=15 micromol/L) (50% vs 9% vs 0%, P=0.016).

    “significantly greater proportion of those in group 1 achieved posttreatment levels <12 micromol/L: group 1, 5 of 10 (50%); group 2, 1 of 11 (9%); and group 3, 0 of 8 (0%)”

    Human trialchronic stable renal transplant recipients with baseline tHcy >=15 micromol/L2.4 mg/d vs 0.4 mg/d and placebo12 weeksn = 29

    Enhanced reduction of fasting total homocysteine levels with supraphysiological versus standard multivitamin dose folic acid supplementation in renal transplant recipients

    Arteriosclerosis, thrombosis, and vascular biology

  2. Folic acid decreases hyperhomocysteinemia in humans.

    “Supplementation with folic acid seems to be effective in reducing hyperhomocysteinaemia”

    Review

    Role of arginine, taurine and homocysteine in cardiovascular diseases

    Annals of medicine

More on Hyperhomocysteinemia

HDL-C

upin humans1

1 study
  1. Folic acid increases HDL-C in humans with resistance training (+0.21 ± 0.24 mmol/L vs -0.01 ± 0.12 mmol/L).

    “The overall group effect was significant for HDL-C only (F = 3.43, P = 0.027).”

    Human trialwith resistance training9 weeksmalesn = 40

    Effects of folic acid combined with resistance training on body composition and blood biomarkers in adult males

    Journal of the International Society of Sports Nutrition

  2. Folic acid increases HDL-C in humans (combined with resistance training) (+0.21 ± 0.24 mmol/L).

    “HDL-C increased more in the RF (+0.21 ± 0.24 mmol/L) than in the control (-0.01 ± 0.12 mmol/L; P < 0.01) and FA (+0.02 ± 0.16 mmol/L; P < 0.05).”

    Human trialcombined with resistance training0.4 mg daily8 weeksmalesn = 40

    Effects of folic acid combined with resistance training on body composition and blood biomarkers in adult males

    Journal of the International Society of Sports Nutrition

More on HDL-C

Skeletal muscle

upin humans1

1 study
  1. Folic acid increases skeletal muscle in humans with resistance training.

    “Between-group analysis of change scores demonstrated a significant overall effect for SMM (F = 12.02, P < 0.001).”

    Human trialwith resistance training9 weeksmalesn = 40

    Effects of folic acid combined with resistance training on body composition and blood biomarkers in adult males

    Journal of the International Society of Sports Nutrition

  2. Folic acid increases skeletal muscle in humans (combined with resistance training) (+4.79 ± 2.42 kg).

    “RF produced the greatest increase in skeletal muscle mass (SMM; + 4.79 ± 2.42 kg), which was significantly larger than the increases observed in the control (+0.96 ± 1.50 kg), FA (+1.03 ± 1.68 kg), and RT (+0.91 ± 1.12 kg)”

    Human trialcombined with resistance training0.4 mg daily8 weeksmalesn = 40

    Effects of folic acid combined with resistance training on body composition and blood biomarkers in adult males

    Journal of the International Society of Sports Nutrition

Endothelial sensitivity to exercise-induced shear rate

no changein humans1

1 study
  1. Folic acid showed no clear effect on endothelial sensitivity to exercise-induced shear rate in humans (handgrip exercise) (P = 0.887).

    “Acute folic acid consumption did not improve endothelial sensitivity to exercise-induced shear rate in females (placebo: 0.102 ± 0.055%·s−1, folic acid: 0.099 ± 0.062%·s−1, P = 0.887)”

    Human trialhandgrip exercisebrachial artery5 mgacutefemalesn = 17

    Endothelial sensitivity to exercise-induced shear rate in older adults: effect of biological sex and acute folic acid consumption

    American journal of physiology. Heart and circulatory physiology

All 88

What is folic acid linked with?

36

Studies link folic acid with 36 measures, most often cognitive impairment (5 studies), colorectal cancer (2) and sarcopenia (2).

Cognitive impairment

downin humans5OR 0.41–0.96

5 studies
  1. Folic acid is linked with a lower risk of cognitive impairment in humans (adjusted for confounding factors; robust to vitamin supplements and comorbidities) (OR 0.777 (95% CI 0.604-0.999), p = 0.034).

    “serum Vitamin D (OR = 0.695, 95% CI: 0.534-0.905, p = 0.003) and FA (OR = 0.777, 95% CI: 0.604-0.999, p = 0.034) levels were inversely correlated with cognitive disorder risk”

    Humansadjusted for confounding factors; robust to vitamin supplements and comorbiditiesn = 2,582

    Relationship Between Serum Vitamins and Cognitive Impairment in the Elderly: A Study Based on the NHANES Database

    Brain and behavior

  2. Folic acid is linked with a lower risk of cognitive impairment in humans (highest vs lowest quartile of intake) (OR = 0.53, 95% CI: 0.31-0.89).

    “total folate (OR = 0.53, 95% CI: 0.31-0.89)”

    Humanshighest vs lowest quartile of intaken = 2,716

    Associations between dietary B vitamin intakes and cognitive function among elderly individuals: An observational study

    Nutrition (Burbank, Los Angeles County, Calif.)

  3. Folic acid is linked with a lower risk of cognitive impairment in subjects with normal cognition.

    “a lower risk of cognitive impairment in those with normal cognitive who consumed VD, folic acid or CoQ10 on a daily basis compared those who did not”

    Humansin subjects with normal cognition

    Study of Diet Habits and Cognitive Function in the Chinese Middle-Aged and Elderly Population: The Association between Folic Acid, B Vitamins, Vitamin D, Coenzyme Q10 Supplementation and Cognitive Ability

    Nutrients

  4. Folic acid is linked with a lower risk of cognitive impairment in humans (multivariate logistic regression, Z test) (OR 0.96, 95% CI: 0.94-0.98).

    “In the multivariate logistic regression, the OR of developing folate was 0.96 (95% CI: 0.94∼0.98) in participants with Z test.”

    Humansmultivariate logistic regression, Z testn = 2,524

    Association between dietary folate intake and cognitive impairment in older US adults: National Health and Nutrition Examination Survey

    Archives of gerontology and geriatrics

  5. Folic acid is linked with a lower risk of cognitive impairment in humans (OR 0.41 (0.19-0.89)).

    “a higher level of plasma folate was associated with lower odds of cognitive impairment. The corresponding odds ratio (OR) with 95% confidence interval was 0.41 (0.19-0.89)”

    Humanstwo yearsn = 615

    Plasma folate levels in relation to cognitive impairment: a community-based cohort of older adults in China

    European journal of nutrition

More on Cognitive impairment

Colorectal cancer

downin humans2RR 0.46

2 studies
  1. Folic acid is associated with colorectal cancer in humans.

    “Total folate intake and folate supplement use were inversely associated with the risk of colorectal cancer”

    Humanssupplements

    Folate and folic acid intake in relation to molecular subtypes of colorectal cancer: pooled analyses of up to 8970 cases and 8098 control participants

    The American journal of clinical nutrition

  2. Folic acid is linked with a lower risk of colorectal cancer in humans among women who were not taking supplements containing folate and vitamin B(6) (RR 0.46 (95% CI: 0.26, 0.81)).

    “dietary intakes of folate and vitamin B(6) were significantly inversely associated with colorectal cancer risk among women who were not taking supplements containing folate and vitamin B(6).”

    Humansamong women who were not taking supplements containing folate and vitamin B(6)dietaryfemalesn = 37,916

    Folate, vitamin B6, multivitamin supplements, and colorectal cancer risk in women

    American journal of epidemiology

More on Colorectal cancer

Sarcopenia

downin humans2OR 0.72

2 studies
  1. Folic acid is linked with a lower risk of sarcopenia in humans (comparing participants in the lowest tertile of folate) (OR 0.72, 95% CI 0.59-0.88).

    “0.72 (95% CI: 0.59, 0.88) for the third tertile”

    Humanscomparing participants in the lowest tertile of folatethird tertile

    Individual and joint association of serum 25-hydroxyvitamin D and folate levels with the risk of sarcopenia: a cross-sectional study from the NHANES 2011-2018

    Frontiers in nutrition

  2. Folic acid is linked with a lower risk of sarcopenia in humans (type 2 diabetes).

    “In diabetic men,higher levels of serum and red blood cell folate were linked to a greater muscle mass index ALMBMI and a lower incidence of sarcopenia.”

    Humanstype 2 diabetesmalesn = 3,371

    Association between folic acid levels and sarcopenia in American adults: evidence from NHANES

    Research SquarePreprint

More on Sarcopenia

Telomere length

upin humans2

2 studies
  1. Folic acid is associated with telomere length in humans (0.016 (95% CI: 0.003; 0.030)).

    “folate (0.016 (0.003; 0.030))”

    Humansmultivariable linear regression adjusting for demographic, lifestyle and clinical characteristics

    Micronutrient intake and telomere length: findings from the UK Biobank

    European journal of nutrition

  2. Folic acid is associated with telomere length in humans (P = 0.05).

    “LTL was positively associated with the consumption of vitamin C (P < 0.05), folate (P = 0.05) and potassium (P = 0.05) in all participants.”

    Humansn = 1,958

    Longitudinal associations between micronutrient consumption and leukocyte telomere length

    Journal of human nutrition and dietetics : the official journal of the British Dietetic Association

More on Telomere length

Health-related quality of life

upin humans2

2 studies
  1. Folic acid is associated with health-related quality of life in humans (premenopausal women with comorbidities) (β = -0.31 (95% CI -0.58 to -0.05) for log of inverse HRQOL scores).

    “Higher intakes of various nutrients (particularly, folic acid and vitamin A) were related to higher HRQOL scores in premenopausal women with comorbidities”

    Humanspremenopausal women with comorbiditiesfemales

    Interactions between nutrient intake and comorbidities for quality of life in premenopausal and postmenopausal women

    Menopause (New York, N.Y.)

  2. Folic acid is associated with health-related quality of life in humans (coefficient: 0.0289; 95% CI 0.0016, 0.0563).

    “Higher folate concentrations were significantly associated with higher HRQOL in the elderly.”

    Humans

    Serum folate concentration and health-related quality of life among the elderly in South Korea

    Health and quality of life outcomes

Mild cognitive impairment

upin humans1OR 1.52

1 study
  1. Folic acid is associated with mild cognitive impairment in humans (Anhui Yangtze River residents) (OR 1.52, 95% CI 1.11–2.08).

    “higher FA intake was linked to elevated MCI risk [OR (95%CI) = 1.52 (1.11-2.08)].”

    HumansAnhui Yangtze River residentshigher dietary intake

    Modifying effects of Folate, Vitamin B₁₂ Status on associations between metals exposure and mild cognitive impairment incidence: A prospective cohort study of adults living along the Yangtze River, China

    Environmental pollution (Barking, Essex : 1987)

More on Mild cognitive impairment

Activities of daily living disability

downin humans1OR 0.73

1 study
  1. Folic acid is linked with a lower risk of activities of daily living disability in humans after covariate adjustment (OR = 0.73; 95% CI: 0.63-0.85).

    “Inverse associations were observed between higher levels of folate (OR = 0.73; 95% CI: 0.63-0.85) and VitD (OR = 0.80; 95% CI: 0.68-0.93) with the risk of ADL disability”

    Humansafter covariate adjustmentn = 3,974

    Associations of metals and micronutrients with functional disability in Chinese older adults: a mixture analysis approach

    Scientific reports

More on Activities of daily living disability

Parkinson's disease

downin humans1HR 0.71

1 study
  1. Folic acid is linked with a lower risk of Parkinson's disease in humans (HR 0.71, 95% CI 0.59-0.85).

    “those in the highest quartile of methionine, vitamin B6, folate, and vitamin B12 had a lower risk of PD (hazard ratio [HR] [95% confidence interval (CI)] = 0.83 [0.69-1.00], 0.75 [0.62-0.90], 0.71 [0.59-0.85]”

    Humans12.27 yearsn = 202,171

    Dietary one‑carbon nutrients and genetic risk in Parkinson disease: a prospective cohort study

    The journals of gerontology. Series A, Biological sciences and medical sciences

More on Parkinson's disease

Cervical intraepithelial neoplasia

downin humans1−26% reduction

1 study
  1. Folic acid lowers the risk of cervical intraepithelial neoplasia in humans (up to 26% reduction).

    “Dose-response meta-analysis indicated that an additional 240-280.5 μg/day of folate supplementation was associated with a reduction in CIN and/or CC risk by up to 26%.”

    Review240-280.5 μg/day

    Association Between Folate Status and Risk of Cervical Cancer: A Systematic Review, Dose-Response Meta-analysis, and Mendelian Randomization Study

    Nutrition reviews

More on Cervical intraepithelial neoplasia

Major adverse cardiovascular events

upin humans1HR 1.34

1 study
  1. Folic acid is associated with major adverse cardiovascular events in humans (Adjusted HR 1.34 (95% CI 1.09–1.64), erythrocyte sedimentation rate model; 1.39 (95% CI 1.14–1.71), C-reactive protein model).

    “the use of folic acid ⩾5 mg daily was associated with a significantly higher risk of MACE”

    HumansRheumatoid arthritis patients taking methotrexate without baseline major adverse cardiovascular events⩾5 mg daily versus 0-<5 mg dailyMedian follow-up of 9 yearsBothsn = 8,405

    High-dose folic acid supplement is associated with increased cardiovascular risk in rheumatoid arthritis patients on methotrexate

    Therapeutic advances in musculoskeletal disease

All 36

Has folic acid been tested in people?

9 of 173 about aging

Yes: 26 trials and 104 observational studies in people have been published, and 173 trials are registered.

Approved

Repurposing

40 of 129

Every condition in trials

  • Birth Weight

    Phase 4Completed2 trials

  • Contraception

    Phase 3Completed4 trials

  • Lymphoma t cell peripheral

    Phase 3Results posted4 trials

  • Poly Cystic Ovary Syndrome

    Phase 3Recruiting2 trials

  • Active Rheumatoid Arthritis

    Phase 3Results posted1 trial

  • Iron Deficiency Anemia of Pregnancy

    Phase 2Completed2 trials

All 19

Stopped

  • NCT00491907TerminatedHeart failure

    recruitment is finished

  • NCT00402883TerminatedLung neoplasm

    Terminated due to bevacizumab and chemoradiotherapy toxicity

  • NCT01704599TerminatedPsoriasis

    side effect and poor clinical outcome

Who is developing folic acid?

2 companies: Shenzhen Ausa Pharmed and Lo.Li.Pharma s.r.l.

Companies
  • Shenzhen Ausa PharmedPhase 4hypertension, MTHFR 677 CC or CT genotype
  • Lo.Li.Pharma s.r.lHPV infection

Trial sponsors

How this record changed

  1. Summary rewritten as its findings changed.

    As it read before

    Folic acid extends lifespan at low doses but shortens it at medium/high doses in one SOD1-G93A mouse study. Independent labs reproduce human homocysteine reductions, but cognitive results conflict. Three trials concern aging; across uses, 74 ended over a year ago without posted results or citing papers; company ties include an author affiliation and trial sponsorship.

  2. Summary rewritten as its findings changed.

    As it read before

    One study in SOD1-G93A mice shows dose-dependent effects: low-dose folic acid extends lifespan, whereas medium and high doses shorten it. High doses induce apoptosis and activate cerebellar NF-κB signaling, while overdose increases cerebellar inflammation.

  3. Summary written from the findings.

Latest

Dec 2025: 3Jan 2026: 9Feb 2026: 12Mar 2026: 9Apr 2026: 4May 2026: 6Jun 2026: 4Jul 2026: 9Aug 2026: 4Sep 2026: 8Oct 2026: 6Nov 2026: 377 papers in 12 months
BMC Sports Science, Medicine & Rehabilitation

Exercise plus folic acid may improve metabolism in men with obesity

A 12-week randomized trial in 44 men aged 23–32 found the largest improvements in blood sugar measures with combined exercise and supplementation.A 12-week randomized trial in 44 men aged 23–32 found the largest improvements in blood sugar measures with combined exercise and supplementation.

Randomized trial · 44 peopleFolic acid

See all 350 papers on folic acid